(Press-News.org) Contact information: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Emerging class of therapeutics represents a coming wave for developers and manufacturers
After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what's to come. The cover story in Chemical & Engineering News, ACS' weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.
Ann M. Thayer, senior correspondent at C&EN, explains that ADCs are essentially molecular missiles. They are made up of a toxic payload (a drug) attached to an antibody that specifically seeks out sick cells, such as tumor cells. They don't release their lethal cargo until they reach their target. The advantages of this approach are clear: It spares healthy cells and lowers drug side effects. It can also extend the life of a drug under an expiring patent or salvage an antibody that was ineffective by itself. ADCs hold a lot of promise. Of the two approved ADCs, one is soon expected to be a blockbuster. About 30 more are in clinical trials with another 100 or more ADCs in the preclinical pipeline. Projections show that by 2018, sales of ADCs could top $5 billion.
On the manufacturing side, because these drugs are so complex, suppliers are still figuring out how to streamline production. At the moment, ADCs are a niche area of manufacturing with only a few contract manufacturing organizations able to put all the pieces together from start to finish. But many are responding and investing millions to expand capacity for this promising new class.
INFORMATION:
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 163,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter Facebook
END
New study examines patterns of cancer screening in Appalachian women
LEXINGTON, Ky. (Jan. 22, 2014) — A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical ...
The unexpected power of baby math
Tel Aviv University researcher finds that adults still think about numbers like kids
Children understand numbers differently than adults. For kids, one and two seem much further apart then 101 and 102, because two is ...
U-Michigan ecologists: No magic bullet for coffee rust eradication
ANN ARBOR—Spraying fungicide to kill coffee rust disease, which has ravaged Latin American plantations since late 2012, is an approach that is "doomed to failure," according to University of Michigan ...
Health disparities among US African-American and Hispanic men cost economy more than $450 billion
Greatest economic burden shouldered by African-American and Hispanic men
African-American men incurred $341.8 billion in excess medical ...
UCLA researchers develop risk calculator to predict survival in heart failure patients
A UCLA team has developed an easy-to-use "risk calculator" that helps predict heart failure patients' chances of survival for up to five ...
New CU-Boulder study shows differences in mammal responses to climate change
Shrews 27 times less likely to respond to climate change than moose
If you were a shrew snuffling around a North American forest, you would be 27 times ...
Modest familial risks for multiple sclerosis
Even though multiple sclerosis is largely caused by genetic factors, the risk of patients' relatives developing the disease is lower than previously assumed. This is the conclusion of a new population registry-based study, ...
Bright star reveals new exoplanet
By studying the star around which the planet revolves, they found that the star's rotation appears to be well-aligned with the planetary movement. The object can be well-studied because the star is relatively bright, it can ...
Drug alternatives to antibiotics may not be perfect, study shows
New types of drug intended for use in place of antibiotics have been given a cautious welcome by scientists.
Researchers have been probing the long-term effectiveness of drugs currently ...
From a carpet of nanorods to a thin film solar cell absorber within a few seconds
This news release is available in German.
Research teams at the Helmholtz-Zentrum Berlin and at the University of Limerick, ...
